IJCM  Vol.2 No.5 , November 2011
Sport in Psychiatric Rehabilitation: A Tool in Pre-Acute, Post-Acute and Chronic Phase
The principal goal of psychiatric rehabilitation is to improve the global functioning of a person who suffer from a mental disorder. New emerging groups of patients meet difficult to attend to a rehabilitation program. Sport represents a new flexible model that can be used in psychiatric rehabilitation. Sport improves physical health and well being, increases sociality, increases self-efficacy and self-esteem. It is well accepted and well tolerated by the patients, too. Its use goes over the chronic phase of illness (typical target of rehabilitation) and it extends to the post-acute and pre acute phase, too.

Cite this paper
nullG. Corretti, C. Martini, P. Greco and F. Marchetti, "Sport in Psychiatric Rehabilitation: A Tool in Pre-Acute, Post-Acute and Chronic Phase," International Journal of Clinical Medicine, Vol. 2 No. 5, 2011, pp. 568-569. doi: 10.4236/ijcm.2011.25093.
[1]   Z. Russinova, N. J. Wewiorski and D. Cash, “Use of Alternative Health Care Practices by Persons with Serious Mental Illnes: Perceived Benefits,” American Journal of Public Health, Vol. 92, No. 10, 2002, pp. 1600-1603. doi:10.2105/AJPH.92.10.1600

[2]   White Paper On Sport, Brussels, 2007. http://ec./Europa.eu/sport/white-paper/index_en.htm

[3]   D. R. Jones, C. Macias, P. J. Barreira, W. H. Fisher, W. A. Hargreaves and C. M. Harding, “Prevalence, Severity, and Co-Occurrance of Chronic Physical Health Problems of Persons with Serious Mental Illness,” Psychiatric Services, Vol. 55, No. 11, 2004, pp. 1250-1257. doi:10.1176/appi.ps.55.11.1250

[4]   C. R. Richardson, G. Faulkner, J. McDevitt, et al., “Integrating Physical Activity into Mental Health Services for Persons with Serious Mental Illness,” Psychiatric Services, Vol. 56, No. 3, 2005, pp. 324-331. doi:10.1176/appi.ps.56.3.324

[5]   A. Fagiolini, A. L. Montejo, P. Thomas, et al., “Physical Health Considerations in Psychiatry: European Views on Recognition, Monitoring and Management,” European Neuropsychopharmacology, Vol. 18, Supplement 2, 2008, p. 3. doi:10.1016/j.euroneuro.2008.02.001

[6]   H. Ascher-Svanum, B. Zhu, D. E. Faries, et al., “The Cost of Relapse in the Treatment of Schizophrenia,” BMC Psychiatry, Vol. 10, No. 2, 2010, pp. .

[7]   A. Charpentier, M. Goudermand and P. Thomas, “Therapeutic Alliance, a Stake in Schizophrenia,” Encephale, Vol. 35, No. 1, 2009, pp. 80-89. doi:10.1016/j.encep.2007.12.009